These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 10384355)

  • 1. [Recurrence and survival in cancer of the rectum: does it depend on the surgeon?].
    Wind P; Peyromaure M
    Gastroenterol Clin Biol; 1999 Mar; 23(3):417-8. PubMed ID: 10384355
    [No Abstract]   [Full Text] [Related]  

  • 2. [Laparoscopic versus open total mesorectal excision for rectal cancer].
    Rosenberg J; Harvald T; Haglind E
    Ugeskr Laeger; 2007 Oct; 169(43):3652-5. PubMed ID: 17967264
    [No Abstract]   [Full Text] [Related]  

  • 3. Adjuvant therapy in rectal cancer: what is the truth?
    Takiuchi H
    Jpn J Clin Oncol; 2006 Apr; 36(4):191-2. PubMed ID: 16684858
    [No Abstract]   [Full Text] [Related]  

  • 4. [Recurrence and survival after conventional low anterior resection for rectal cancer].
    Bülow S; Moesgaard FA; Crone PO; Gandrup P; Holm J; Kronborg O; Hemmert-Lund H; Myrhøj T; Petersen RH; Qvist N; Raskov HH; Thomsen H
    Ugeskr Laeger; 2001 Jul; 163(27):3793-7. PubMed ID: 11466988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The surgeon as prognostic factor for local recurrence and survival in the anal sphincter preservation for mid-rectal cancer.
    Luna-Pérez P; Reyna Huelga A; Labastida Almendaro S; Rodríguez-Coria DF; González Macouzet J; Delgado Gallardo S
    Rev Invest Clin; 1999; 51(4):205-13. PubMed ID: 10546501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of resection of stage IV rectal cancer with mesorectal excision.
    Law WL; Chu KW
    J Surg Oncol; 2006 Jun; 93(7):523-8. PubMed ID: 16705728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How does surgical technique affect outcomes in rectal cancer?
    Scholefield JH
    J Gastroenterol; 2000; 35 Suppl 12():126-9. PubMed ID: 10779232
    [No Abstract]   [Full Text] [Related]  

  • 8. Oncological outcomes after total mesorectal excision for cure for cancer of the lower rectum: anterior vs. abdominoperineal resection.
    Wibe A; Syse A; Andersen E; Tretli S; Myrvold HE; Søreide O;
    Dis Colon Rectum; 2004 Jan; 47(1):48-58. PubMed ID: 14719151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Total excision of the mesorectum in cancer of the lower and middle rectum. Oncological and functional results].
    Kneist W; Heintz A; Wolf HK; Junginger T
    Chirurg; 2003 Feb; 74(2):125-31. PubMed ID: 12599030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rectal cancer: the impact of a colorectal unit on the preservation of the anal sphincter.
    Heldenberg E; Vishne TH; Onaka N; Dreznik Z
    Isr Med Assoc J; 2004 Aug; 6(8):471-3. PubMed ID: 15326826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The surgeon as a prognostic factor in the treatment of cancer of the rectum].
    Cunsolo A; De Cataldis A; De Raffaele E
    Chir Ital; 2002; 54(2):185-93. PubMed ID: 12038109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local recurrence and survival rates after extended systematic lymph-node dissection for surgical treatment of rectal cancer.
    Hasdemir O; Cöl C; Yalçin E; Tunç G; Bilgen K; Kuçukpinar T
    Hepatogastroenterology; 2005; 52(62):455-9. PubMed ID: 15816456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of total pelvic exenteration for locally recurrent rectal cancer.
    Ike H; Shimada H; Ohki S; Yamaguchi S; Ichikawa Y; Fujii S
    Hepatogastroenterology; 2003; 50(51):700-3. PubMed ID: 12828064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total mesorectal excision for middle and lower rectal cancer: a single institution experience with 337 consecutive patients.
    Piso P; Dahlke MH; Mirena P; Schmidt U; Aselmann H; Schlitt HJ; Raab R; Klempnauer J
    J Surg Oncol; 2004 Jun; 86(3):115-21. PubMed ID: 15170648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome of anastomosis leakage after curative resection for mid and low rectal cancer.
    Chang SC; Lin JK; Yang SH; Jiang JK; Chen WC; Lin TC
    Hepatogastroenterology; 2003; 50(54):1898-902. PubMed ID: 14696429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The surgeon as a prognostic factor in the surgical treatment of rectal cancer.
    Di Cataldo A; Scilletta B; Latino R; Cocuzza A; Li Destri G
    Surg Oncol; 2007 Dec; 16 Suppl 1():S53-6. PubMed ID: 18023175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posterior pelvic exenteration for primary rectal cancer.
    Bannura GC; Barrera AE; Cumsille MA; Contreras JP; Melo CL; Soto DC; Mansilla JE
    Colorectal Dis; 2006 May; 8(4):309-13. PubMed ID: 16630235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy].
    Thomschke D; Kyau-Ummen B; Halbfass HJ
    Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of type of operation for distal rectal cancer: survival, outcomes, and recurrence.
    Chiappa A; Biffi R; Zbar AP; Bertani E; Luca F; Pace U; Biella F; Grassi C; Zampino G; Fazio N; Pruneri G; Poldi D; Venturino M; Andreoni B
    Hepatogastroenterology; 2007 Mar; 54(74):400-6. PubMed ID: 17523284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical outcomes after total mesorectal excision for rectal cancer.
    Chiappa A; Biffi R; Bertani E; Zbar AP; Pace U; Crotti C; Biella F; Viale G; Orecchia R; Pruneri G; Poldi D; Andreoni B
    J Surg Oncol; 2006 Sep; 94(3):182-93; discussion 181. PubMed ID: 16900534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.